The client is a biopharmaceutical company focused on antibody-based therapies across various therapeutic areas. The Chief Executive Officer (CEO) is responsible for strategically defining and executing the client's overall direction, ensuring alignment with Board-approved goals and milestones, particularly in central nervous system (CNS) drug development. The role emphasizes leadership in equity financing and managing investor relations, positioning the client for future funding and growth. Additionally, the CEO will spearhead strategic partnerships, licensing, and collaborations, while overseeing operations, including R&D, regulatory, clinical, and manufacturing readiness. Effective engagement with the Board is crucial, ensuring clear communication and governance.
A suitable candidate will be a proven CEO or serial entrepreneur with direct experience in CNS-related disease areas such as Alzheimer's or Parkinson's disease. They must have a strong track record in venture fundraising and strategic deal-making, demonstrating success in advancing products from early discovery through development via partnerships. The role requires an entrepreneurial mindset, capable of hands-on leadership in a dynamic biotech environment. The client is committed to inclusivity, encouraging applications from underrepresented groups and all qualified individuals.
The position offers a competitive base salary between $350,000 and $450,000, with a performance-based bonus of 40%. It presents a unique opportunity to lead a mid-sized company within the life sciences industry. The client promotes a collaborative and forward-thinking culture, making it an attractive workplace for a driven and strategic leader looking to make a significant impact in the biopharmaceutical field.